These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 19147750)

  • 21. Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer.
    Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Buchsbaum DJ; Vickers SM; Heslin MJ; Arnoletti JP
    Surgery; 2007 Apr; 141(4):464-9. PubMed ID: 17383523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer.
    Zhang X; Zhao Y; Wang M; Yap WS; Chang AY
    Lung Cancer; 2008 May; 60(2):175-82. PubMed ID: 18061305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.
    Liu W; Wu X; Zhang W; Montenegro RC; Fackenthal DL; Spitz JA; Huff LM; Innocenti F; Das S; Cook EH; Cox NJ; Bates SE; Ratain MJ
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6788-95. PubMed ID: 18006781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy.
    Qin BM; Chen X; Zhu JD; Pei DQ
    Cell Res; 2005 Mar; 15(3):212-7. PubMed ID: 15780185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor mutations in lung cancer.
    Sharma SV; Bell DW; Settleman J; Haber DA
    Nat Rev Cancer; 2007 Mar; 7(3):169-81. PubMed ID: 17318210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of EGFR pathway-related genes in the circulation is highly correlated with EGFR mutations and overexpression in paired cancer tissue from patients with non-small cell lung cancer.
    Chen CC; Chiu HH; Yen LC; Chang HJ; Chang MS; Tsai JR; Chen YF; Lin SR
    Oncol Rep; 2010 Mar; 23(3):639-45. PubMed ID: 20127001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response.
    Gow CH; Chien CR; Chang YL; Chiu YH; Kuo SH; Shih JY; Chang YC; Yu CJ; Yang CH; Yang PC
    Clin Cancer Res; 2008 Jan; 14(1):162-8. PubMed ID: 18172267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
    Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272.
    Minami Y; Shimamura T; Shah K; LaFramboise T; Glatt KA; Liniker E; Borgman CL; Haringsma HJ; Feng W; Weir BA; Lowell AM; Lee JC; Wolf J; Shapiro GI; Wong KK; Meyerson M; Thomas RK
    Oncogene; 2007 Jul; 26(34):5023-7. PubMed ID: 17311002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on the role of epidermal growth factor receptor inhibitors in non-small cell lung cancer.
    Edelman MJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S3-8. PubMed ID: 16459173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
    Modjtahedi H; Essapen S
    Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.
    Inoue A; Kobayashi K; Usui K; Maemondo M; Okinaga S; Mikami I; Ando M; Yamazaki K; Saijo Y; Gemma A; Miyazawa H; Tanaka T; Ikebuchi K; Nukiwa T; Morita S; Hagiwara K;
    J Clin Oncol; 2009 Mar; 27(9):1394-400. PubMed ID: 19224850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.
    Nagahara H; Mimori K; Ohta M; Utsunomiya T; Inoue H; Barnard GF; Ohira M; Hirakawa K; Mori M
    Clin Cancer Res; 2005 Feb; 11(4):1368-71. PubMed ID: 15746034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activating and resistance mutations of the epidermal growth factor receptor (EGFR) gene and non-small cell lung cancer: a clinical reality.
    Taus A; Vollmer I; Arriola E
    Arch Bronconeumol; 2011 Feb; 47(2):103-5. PubMed ID: 20678850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
    Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
    Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.
    Eberhard DA; Giaccone G; Johnson BE;
    J Clin Oncol; 2008 Feb; 26(6):983-94. PubMed ID: 18281673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.
    Mustea A; Sehouli J; Fabjani G; Koensgen D; Möbus V; Braicu EI; Pirvulescu C; Thomas A; Tong D; Zeillinger R
    Anticancer Res; 2007; 27(3B):1527-30. PubMed ID: 17595771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of epidermal growth factor receptor antisense morpholino oligomer on non-small cell lung cancer cell line.
    Washio K; Aoe M; Toyooka S; Mushiake H; Tsukuda K; Shimizu N
    Oncol Rep; 2003; 10(6):1967-71. PubMed ID: 14534727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on epidermal growth factor receptor mutations in non-small cell lung cancer.
    Riely GJ; Politi KA; Miller VA; Pao W
    Clin Cancer Res; 2006 Dec; 12(24):7232-41. PubMed ID: 17189394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.